1. Home
  2. INBX vs ARAY Comparison

INBX vs ARAY Comparison

Compare INBX & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INBX
  • ARAY
  • Stock Information
  • Founded
  • INBX 2010
  • ARAY 1990
  • Country
  • INBX United States
  • ARAY United States
  • Employees
  • INBX N/A
  • ARAY N/A
  • Industry
  • INBX Biotechnology: Pharmaceutical Preparations
  • ARAY Medical/Dental Instruments
  • Sector
  • INBX Health Care
  • ARAY Health Care
  • Exchange
  • INBX Nasdaq
  • ARAY Nasdaq
  • Market Cap
  • INBX 218.9M
  • ARAY 180.0M
  • IPO Year
  • INBX 2020
  • ARAY 2007
  • Fundamental
  • Price
  • INBX $13.92
  • ARAY $1.82
  • Analyst Decision
  • INBX Hold
  • ARAY Strong Buy
  • Analyst Count
  • INBX 1
  • ARAY 1
  • Target Price
  • INBX N/A
  • ARAY $9.00
  • AVG Volume (30 Days)
  • INBX 81.4K
  • ARAY 659.9K
  • Earning Date
  • INBX 11-14-2024
  • ARAY 01-29-2025
  • Dividend Yield
  • INBX N/A
  • ARAY N/A
  • EPS Growth
  • INBX N/A
  • ARAY N/A
  • EPS
  • INBX 119.38
  • ARAY N/A
  • Revenue
  • INBX $1,568,000.00
  • ARAY $444,204,000.00
  • Revenue This Year
  • INBX N/A
  • ARAY $6.64
  • Revenue Next Year
  • INBX N/A
  • ARAY $5.69
  • P/E Ratio
  • INBX $0.12
  • ARAY N/A
  • Revenue Growth
  • INBX 19.24
  • ARAY N/A
  • 52 Week Low
  • INBX $10.80
  • ARAY $1.40
  • 52 Week High
  • INBX $18.95
  • ARAY $3.05
  • Technical
  • Relative Strength Index (RSI)
  • INBX 38.33
  • ARAY 43.76
  • Support Level
  • INBX $14.53
  • ARAY $1.75
  • Resistance Level
  • INBX $15.24
  • ARAY $1.98
  • Average True Range (ATR)
  • INBX 0.72
  • ARAY 0.09
  • MACD
  • INBX -0.10
  • ARAY -0.03
  • Stochastic Oscillator
  • INBX 19.16
  • ARAY 20.51

About INBX Inhibrx Inc.

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

About ARAY Accuray Incorporated

Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.

Share on Social Networks: